The orders were granted in the High Court to a number of UK-based Japanese pharmaceutical companies and their staff under the Protection from Harassment Act 1997. They relate to named individuals and organisations involved in animal rights campaigning to prevent them harassing the claimants' employees, families and those associated with them.
"Animal research is absolutely fundamental to the development of new medicines to help people suffering from illness and disease," said Andrew Curl, Deputy Director General of the ABPI.
"While those who oppose such work have every right to make their views known, many companies and staff have experienced quite unacceptable levels of harassment and attacks. I am delighted that the High Court has granted these orders preventing such activity."
Recent harassment targeted at some Japanese pharmaceutical companies and previously outlined in the High Court has included fire bombings, assaults on staff, intimidatory visits to staff homes, threatening, offensive and malicious letters and telephone calls, and criminal damage to individuals' property.
The companies who gained the injunction were:
ACT Tech UK Limited
Asahi Glass Fluoropolymers UK Limited
Daiichi Pharmaceuticals UK Limited
Eisai Limited
Eisai London Laboratories Limited
F2 Chemicals Limited
Sankyo Pharma UK Limited
Yamanouchi Pharma Limited
Yamanouchi UK Limited
For further information, please contact: ABPI Press Office 020 7747 1410